Drug intelligence / Profile preview

Baoze Capsule

Development stage: Unknown
Lead developer: Sichuan Institute of Traditional Chinese Medicine
Administration: Oral

Overview

**Baoze Capsule** is an investigational oral traditional Chinese medicine or natural-drug capsule developed for **melasma**, specifically the traditional Chinese medicine syndrome pattern described as liver-qi stagnation, kidney deficiency, qi stagnation, and blood stasis. A randomized, double-blind, dose-parallel, multicenter Phase II study evaluated its efficacy, safety, and dose selection in this population. The individual active constituents and molecular mechanism have not been identified in the publicly available trial information.

Other names: 葆泽胶囊

Beyond the preview

Go deeper on Baoze Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baoze Capsule.

Explore the full profile